Abcam, ab263262, Human MTMR2 knockout HeLa cell lysate

Size: 1Kit
MTMR2 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 5 and Insertion of the selection cassette in exon 5.
Key facts
Cell type:HeLa,
Species or organism:Human,
Tissue:Cervix,
Knockout validation:Sanger Sequencing,
Mutation description:Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 5 and Insertion of the selection cassette in exon 5.,
Disease:Adenocarcinoma

Product details:
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation:
Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10).
This means that the protein of interest is denatured.
If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions:
Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-MTMR2, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Shipped at conditions-Ambient - Can Ship with Ice, Appropriate short-term storage conditions--20°C, Appropriate long-term storage conditions--20°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
MTMR2 also known as Myotubularin Related Protein 2 acts as a phosphatidylinositol 3-phosphatase with a molecular weight of approximately 72 kDa. It belongs to the myotubularin family and is widely expressed in several tissues including peripheral nerves and the brain. This protein plays an important role in the regulation of phosphatidylinositol signaling pathways involving dephosphorylation processes essential for cellular homeostasis.
Biological function summary
MTMR2 facilitates the regulation of membrane trafficking and endosomal processing by controlling phosphoinositide levels. It operates as part of larger protein complexes interacting with other members of the myotubularin family. This collaboration is important for maintaining cellular dynamics and integrity influencing processes such as cell growth and cytoskeletal organization. These actions are necessary for proper nerve function and development.
Pathways
MTMR2 is mainly involved in phosphatidylinositol signaling and endocytic pathways. This protein interacts closely with PI3K influencing the PI3K-Akt signaling pathway critical for cell survival and proliferation. Connections also occur with proteins such as MTMR5 which facilitate further regulatory controls. These pathways highlight the role of MTMR2 in cellular signal transduction and its influence on cell morphology.
MTMR2 mutations are associated with Charcot-Marie-Tooth disease type 4B1 a peripheral neuropathy characterized by demyelination and muscle weakness. This connection involves an alteration in the pathway regulating phosphoinositide metabolism impacting proper nerve function. Additionally MTMR2 shows interaction with MTMR13 implicating a combined role in the pathogenesis of this disorder. Another disorder linked to MTMR2 dysfunction is myotubular myopathy which affects muscle strength and coordination. This further exemplifies the importance of MTMR2 in maintaining normal physiological conditions.